
Co-Diagnostics Inc (NASDAQ:CODX) shares are trading higher in Thursday's after-hours session after the company reported financial results and issued earnings guidance.
Co-Diagnostics reported full year 2021 revenue of $97.89 million, which is up $23.3 million year-over-year. The company reported earnings of $1.23 per share, which was down from earnings of $1.52 per share in 2020.